PMID- 23560031 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20130408 LR - 20220321 IS - 1874-3641 (Print) IS - 1874-3641 (Electronic) IS - 1874-3641 (Linking) VI - 7 DP - 2013 TI - Correlation from undiluted vitreous cytokines of untreated central retinal vein occlusion with spectral domain optical coherence tomography. PG - 11-7 LID - 10.2174/1874364101307010011 [doi] AB - PURPOSE: To correlate inflammatory and proangiogenic key cytokines from undiluted vitreous of treatment-naive central retinal vein occlusion (CRVO) patients with SD-OCT parameters. METHODS: Thirty-five patients (age 71.1 years, 24 phakic, 30 nonischemic) underwent intravitreal combination therapy, including a single-site 23-gauge core vitrectomy. Twenty-eight samples from patients with idiopathic, non-uveitis floaterectomy served as controls. Interleukin 6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and vascular endothelial growth factor (VEGF-A) levels were correlated with the visual acuity (logMar), category of CRVO (ischemic or nonischemic) and morphologic parameters, such as central macular thickness-CMT, thickness of neurosensory retina-TNeuro, extent of serous retinal detachment-SRT and disintegrity of the IS/OS and others. RESULTS: The mean IL-6 was 64.7pg/ml (SD +/- 115.8), MCP-1 1015.7 ( +/- 970.1), and VEGF-A 278.4 ( +/- 512.8), which was significantly higher than the control IL-6 6.2 +/- 3.4pg/ml (P=0.06), MCP-1 253.2 +/- 73.5 (P<0.0000001) and VEGF-A 7.0 +/- 4.9 (P<0.0006). All cytokines correlated highly with one another (correlation coefficient r=0.82 for IL-6 and MCP-1; r=0.68 for Il-6 and VEGF-A; r=0.64 for MCP-1 and VEGF-A). IL-6 correlated significantly with CMT, TRT, SRT, dIS/OS, and dELM. MCP-1 correlated significantly with SRT, dIS/OS, and dELM. VEGF-A correlated not with changes in SD-OCT, while it had a trend to be higher in the ischemic versus the nonischemic CRVO group (P=0.09). CONCLUSIONS: The inflammatory cytokines were more often correlated with morphologic changes assessed by SD-OCT, whereas VEGF-A did not correlate with CRVO-associated changes in SD-OCT. VEGF inhibition alone may not be sufficient in decreasing the inflammatory response in CRVO therapy. FAU - Koss, Mj AU - Koss M AD - Department of Ophthalmology, Goethe University, Frankfurt am Main, Germany ; Doheny Eye institute, Los Angeles, USA. FAU - Pfister, M AU - Pfister M FAU - Rothweiler, F AU - Rothweiler F FAU - Rejdak, R AU - Rejdak R FAU - Ribeiro, R AU - Ribeiro R FAU - Cinatl, J AU - Cinatl J FAU - Schubert, R AU - Schubert R FAU - Kohnen, T AU - Kohnen T FAU - Koch, Fh AU - Koch F LA - eng PT - Journal Article DEP - 20130308 PL - Netherlands TA - Open Ophthalmol J JT - The open ophthalmology journal JID - 101480505 PMC - PMC3613771 OTO - NOTNLM OT - CBA OT - CRVO OT - IL-6 OT - MCP-1 OT - SD-OCT. OT - VEGF OT - Vitreous samples EDAT- 2013/04/06 06:00 MHDA- 2013/04/06 06:01 PMCR- 2013/01/01 CRDT- 2013/04/06 06:00 PHST- 2012/12/19 00:00 [received] PHST- 2013/01/15 00:00 [revised] PHST- 2013/01/15 00:00 [accepted] PHST- 2013/04/06 06:00 [entrez] PHST- 2013/04/06 06:00 [pubmed] PHST- 2013/04/06 06:01 [medline] PHST- 2013/01/01 00:00 [pmc-release] AID - TOOPHTJ-7-11 [pii] AID - 10.2174/1874364101307010011 [doi] PST - ppublish SO - Open Ophthalmol J. 2013;7:11-7. doi: 10.2174/1874364101307010011. Epub 2013 Mar 8.